chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around November 7, I got up in the morning and my right knee was swollen. I thought it was from overworking, so I wrapped it and took Aleve. After a week, the swelling went down but it was still achy and everything. It got to the point where I took Aleve or ibuprofen, it became tolerable. March 18, 2022. I finally decided to go to an orthopedic surgeon because it was still aching. An x-ray showed that there was some arthritis there and he prescribed prednisone and stuff to get the joint pain down and the swelling. I had to go to a doctor on April 10, 2022, more prednisone and that was an ER visit. Prednisone and cream to put on the joint. I ended up going to the hospital because I was in a lot of pain with my knee and that was on April 17, 2022. They gave me more prednisone. April 19, 2022, I went back and I had an episode where every joint in my body was hurting. According to the orthopedic doctor, he said it looked like I had rheumatoid arthritis, and that I was having a flare up. One of the first things he asked was if I had my booster vaccine. And it has us thinking about how this started in November. Doctor said we don't have all the facts, but he noted he had seen an increase with arthritis and RA. Currently taking arthritis strength Tylenol a couple times a day, 30mg prednisone, daily medications. It's pretty much under control, but this morning the knee is throbbing and a couple other joints are hurting. There are good days and bad days.
Pulmonary Edema, Dyspnea, Shortness of breath, Fatigue
Sore arm first two days  After 48 hours. ::  Rapid breathing (could have been my regular heart valve racing condition) Extreme dizziness unable to stand or walk for a bit  Extreme weakness and fatigue in legs  Slight nausea  Slight headache
A father reported that his son received his first dose of Prevnar and his second dose of DTaP on 03/22/2001. Within hours the infant developed a rash on his face which spread to his neck. The reporter indicated that the infant received 2 other vaccines, however they were not identified.
I had a high fever 101.5-102 for 24 hours following the first vaccine. 3 days later the fatigue, severe headaches, muscle aches , racing heart 110-120 at rest and random spikes in BP (149/97)began and lasted on and off until the second vaccine. After the second vaccine the symptoms persisted until it developed into a backache on 2/26/21 that worsened until developing extreme pain, difficulty breathing, shortness of breath at 3:30 am on 3/2/21
Increased body temperature around 4/10 10:00 PM. Took 440 mg of Naproxen Sodium (2 Caps). Through the night, fever and chills (with cold hands and feet. As of getting up from bed around 11:00 AM, still feeling chills and fever, back ache has increased. Took another 440 mg  of Naproxen Sodium and putting feet near a heater fan.
Report A0370076A describes hair loss in a 17 y.o. female who received Hep B vaccine recombinant (Engerix-B). This report was received from the mother of the vaccinee and has not been verified by a physician or other healthcare professional. The medical history and concurrent conditions were not specified. Concurrent medications reportedly included thiamazole (Tapazole). According to the mother, the vaccinee received her first injection of Engerix-B in June 99. Reportedly, in the summer & fall of 99, the vaccinee "experienced hair loss from her hair line above her temples - similar to how a man loses his hair. It grew back later." Reportedly, the vaccinee received her second and 3rd injections of Engerix-B in July & October 2000, respectively. The hair loss reportedly revolved in winter 2000.
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients. On unknown dates, the patients were vaccinated with doses of PNEUMOVAX23, (lot #, expiration date and dose unspecified) that were exposed to 8.5 degree centigrade to 12 degree centigrade for 158.5 hours, which was an excursion that was not supported by in-house stability data. No adverse effect reported. This is one of several reports received from same source. Additional information has been requested.
Person was given 0.3cc dose of Janssen Booster dose instead of standard 0.5 cc. Notified and Manufacturer (Janssen) notified and all persons reported to Janssen Manufacturer for their Pharmacy department, recommendations from the Manufacturer and with agreement from Department of Health are to notify all of the recipients that received an incorrect dose and submit a VAERS report for each.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy, Alcohol use (Social drinks, 3-4 drinks a week-no alcohol durning pregnancies) in 2006 and Cigarette smoker (Got up to 3 packs a week) from 2003 to 2011. Concurrent medical conditions included Asthma (exacerbated by any respiratory infection, not chronic condition). Concomitant products included LORATADINE (CLARITIN [LORATADINE]) from 04-Feb-2021 to an unknown date and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Nutritional supplement, PARACETAMOL (TYLENOL) for Pain, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 24-Dec-2020 and the estimated date of delivery was 30-Sep-2021. On 25-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  On 21-Feb-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Ultrasound foetal: establish there was a fetus. On 25-Apr-2021, Blood test: to be complete 23APR2021.   This case was linked to MOD-2021-048015 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: follow-up was received on 06-may-2021, medical history and lab data were updated
This spontaneous report was received from a nurse regarding unspecified number of patients of unknown age and gender. On an unknown date, the unspecified patients were vaccinated with PROQUAD (Merck) (Lot # L023114, expiry: 24-DEC-2016; Lot# L016394, expiry: 08-NOV-2016; Lot3 L007229, expiry: 03-SEP-2016) (route, dose and strength were not reported), which was improperly stored at -12.7 degree centigrade for 9 hours and 58 minutes. No adverse effects were reported. There was no prior temperature excursions and data logger was involved. This is one of the several cases from the same reporter. Additional information has been requested.
Jannsen vaccine was requested by mother for her daughter age 15. Pharmacy student did not verify patient age and administered vaccine
Chills, headache, nausea, Joint Pain Red raised hot area at injection site- got better by Thursday - Symptoms  returned including Rash arm on following Tuesday
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Thyroid cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid from 14Aug2023 to 18Aug2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300291425 Same patient, different event/drug;
12OCT @ inj site lt deltoid pt noted small (dime size) water filled blister;13OCT same;14OCT blister deflated;115OCT red scab remaining;
This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 14-JUN-2022 for prophylactic vaccination. The drug was associated with Medication error. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-JUN-2022, the patient experienced vaccine administered from a vial that was left at room temperature for 2 hours 30 minutes, and incorrect product storage. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered from a vial that was left at room temperature for 2 hours 30 minutes and incorrect product storage was not reported. This report was non-serious.
low grade fever; aches and pain; is a little fatigue; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever), PAIN (aches and pain), FATIGUE (is a little fatigue) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (low grade fever), PAIN (aches and pain), FATIGUE (is a little fatigue) and INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Felt cold going up shoulder 10 minutes after receiving vaccine.  Tingling all the way down arm to fingertips 3-4 hours after vaccine.  Fatigue for at least 3 days.  Pain in center of chest ongoing for 3 days.  Feels like I've just finished a workout in terms of heart beating hard - intermittently for 3 days.  I hope this goes away soon.
pale color, dizzy. Placed supine, MD assessed; lungs clear without wheezing, without swelling of lips, given juice. Responded well to tx. Discharged by MD with parents.
About 10 days post vaccination, pt developed rash at inject site. Rash was 2 cm inches diameter and tender.
A vaccine expired by 8 hours was administered as a first dose to a female patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A vaccine expired by 8 hours was administered as a first dose to a female patient) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A vaccine expired by 8 hours was administered as a first dose to a female patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A vaccine expired by 8 hours was administered as a first dose to a female patient) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported .   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow Up received on 03-JUN-2021 Contains Updated Reporter Information, Facility Information,Patient demographic details and Vaccination Time
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 7/10/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/26/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE D68.9 COAGULOPATHY, UNSPECIFIED TYPE 7/10/2022 ASCENDING THORACIC AORTIC ANEURYSM J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/26/2022 ASCENDING THORACIC AORTIC ANEURYSM
He was given his first Moderna vaccine on 7/20/2022 and his second was administered on 8/10/2022, only 3 weeks later.
rash on his palm of hands, fingers, sole of his feet, between his toes; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on his palm of hands, fingers, sole of his feet, between his toes) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included SIMVASTATIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RASH (rash on his palm of hands, fingers, sole of his feet, between his toes). At the time of the report, RASH (rash on his palm of hands, fingers, sole of his feet, between his toes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Health care provider prescribed Prednisone for treatment.
Right shoulder soreness with decreased ROM; injection site soreness; This is a spontaneous report from a contactable physician (patient). A 66-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3248) via intramuscular route of administration, administered in Arm Right on 12Jan2021 15:00 (at the age of 66 years old) as dose 2, single for COVID-19 immunisation at hospital. Medical history included asthma, breast Cancer survivor x 10 years, osteopenia. Concomitant medication received within two weeks included fluticasone propionate, salmeterol xinafoate (ADVAIR) taken for asthma, start and stop date were not reported. The patient previously took tussionex [hydrocodone;phenyltoloxamine] and experienced allergy. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EK5730) via intramuscular route of administration, administered in Arm Right on 23Dec2020 06:30 (at the age of 66 years old) as single for COVID-19 immunisation. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced injection site soreness on 12Jan2021, right shoulder soreness with decreased rom on 14Jan2021 12:45. Reported as, within 6-8 hours of injection, usual expected injection site soreness occurred, but then within 48 hours this intensified and Right shoulder soreness with decreased ROM that barely responded to acetaminophen 500-650 mg BID- TID. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient did not tested for COVID post vaccination. Therapeutic measures were taken as a result of injection site soreness, right shoulder soreness with decreased rom. Outcome of all the events were recovering.  Follow-up attempts completed. No further information expected.
After giving pt injection Mother instructed pt to put head between legs and mentioned to RPH that he gets dizzy sometimes. Pt stood up after about 30 seconds and moved to other chair in room. While waiting for last sibling to receive their immunization (3 siblings all receiving flu vaccine) patient fainted and convulsed for about 5 seconds. He then regained consciousness and took another 5 seconds to respond to questions. We (Mother and I) laid patient on floor and brought him water and a cold towel.   Monitored patient for additional signs of syncope for another 5-10 min.  She mentioned during this time that patient had a similar event in the past in a closed environment where he got hot and dizzy and fainted but that this was the first  vaccine related issue. Pt reported feeling better after this and mother elected to take patient home.
Received immunization around 9 a.m. 11/1/2006; Patient states she had pulse rate increase;  Chest pains; Trouble Swallowing; Rash all over from head to toe; itching; Tight hissing in Throat afternoon of 11/1/2006; Saw PMD and CNP 11/01/2006 afternoon.
I have a large red, itchy, and warm to the touch spot where the shot was given. My arm was sore for a few days after the shot they got itchy and now has a red mark.
Developed asymptomatic diffuse pink rash of trunk, and left arm (the vaccinated arm) resolved in 72 hrs by 70%.
irritable, lack of appetite x4hr;no sleep-local redness & tender to touch;
about 10 minutes after the injection I was walking around the store and had a very sharp and jolting almost zap in my head.  Then my heart rate jumped to about 135bpm from what was around an average of 75bpm prior.  I got very dizzy, weak in my whole body and began having cold sweats.   My next event was 11-26-2021.  I had extreme muscle weakness, tingling in my limbs and felt dizzy.  I went to the ER and they ran thyroid blood work, and a CBC.  All came back normal.  They also performed a CT scan with contrast and to look for clotting.  All looked ok. Over the next 3 weeks I went to the ER 2 more times, once in an ambulance.  Same symptoms: weakness that one day is on my right side, then to my left, sometimes my entire body.  The time I went to the er in an ambulance, was due to sever weakness and very high jump in heart rate while sitting and reading in my home town.  I had chest x rays (not sure why) and more blood work...all came back normal.  I have NEVER experience anything like this in my 40 years until after I received the JNJ covid 19 shot.
This case was reported by a pharmacist and described the occurrence of vaccine underdose in a 11-year-old male patient who received BOOSTRIX (batch number 3P9CL, expiry date 15th April 2016). Previously experienced adverse reactions included nonspecific reaction (The patient had reactions to other vaccines, not identified, in the past). In 2014, the patient received the 1st dose of BOOSTRIX (unknown) .1 ml. On an unknown date, an unknown time after receiving BOOSTRIX the patient experienced vaccine underdose and off label use. On an unknown date, the outcome of the vaccine underdose and off label use were unknown. Additional information was provided. The office only gave him 0.1mL of the dose to see how the patient responds (no AE events from the administration reported by RPh). The 0.1mL dose was administered at 9:15AM this AM and wants to give the remainder today. The administration is not at the pharmacy by at a clinic (allergist). No adverse event was reported.
Information has been received from a registered pharmacist concerning a 27 year old female patient. On 05-SEP-2012, the patient was vaccinated with a dose of M-M-R II (Lot #: 1251AA; Expiration date: 01-AUG-2013) intramuscularly instead of subcutaneously. Pharmacist reported that when the patient received the M-M-R II, she reported that she experienced some stinging at the injection site on 05-SEP-2012 which quickly resolved. The patient did not seek medical attention. No treatment was given for the event. On the same date "05-SEP-2012", the patient had recovered from the stinging at the injection site. Additional information has been requested.
This spontaneous report as received from a Licensed Practical Nurse refers to unknown number of patients of unknown age and gender. On unknown dates, the patients were inadvertently administered PROQUAD (Merck), that had been improperly stored (dosage, lot # and route of administration not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as there was no consent to contact physician.
not feeling good; chills; fever, which she thought was a 100.1; headache; nausea; started throwing up; This is a spontaneous report from a contactable consumer (patient herself). A 76-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3246, NDC/UPC number and expiry date were unknown), via an unspecified route of administration on 31Jan2021 at a single dose for COVID-19 immunization. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were unknown) on an unspecified date for COVID-19 immunization. Relevant medical history included heart problem, for which the patient did take "medicine," but it was not specified. All day on 01Feb2021, the patient was not feeling good; she had chills all day and then she had a fever, which she thought was a 100.1; and she had a headache; she had nausea and she started throwing up. The patient did not receive any treatment for the events. The outcome of all the events was unknown.
Severe screaming/crying upwards of 3.5 hours approximately 36 hours after vaccination. Child was turning blue the crying was so severe. Inconsolable and completely out of character. 99.9 fever. Lethargy/drowsiness for 4 days after vaccination (12/8-12/12).
Metallic taste in the mouth, and my whole body odor smells like metal its been going on now for 8 days, have a headache, my palms are sweating.
At 7am after a good night's sleep I started feeling a mild headache, naseua, muscle aches and chills.  Took Tylenol and slept 3.5 hrs.  Woke up w a mild elevated temperature, but all other symptoms had nearly completely subsided. Rested the remainder of the day and felt fine the following day.